Issue 29, 2012

Iminosugar–ferrocene conjugates as potential anticancer agents

Abstract

We prepared a series of new iminosugar–ferrocene hybrids displaying potent inhibition of fucosidase (bovine kidney) and inactivation of MDA-MB-231 breast cancer cells proliferation at low micromolar concentrations. The synthetic route brought to light an unprecedented isomerisation of a 2-ethanalylpyrrolidine.

Graphical abstract: Iminosugar–ferrocene conjugates as potential anticancer agents

Supplementary files

Article information

Article type
Paper
Submitted
12 Mar 2012
Accepted
08 Jun 2012
First published
13 Jun 2012

Org. Biomol. Chem., 2012,10, 5592-5597

Iminosugar–ferrocene conjugates as potential anticancer agents

A. Hottin, F. Dubar, A. Steenackers, P. Delannoy, C. Biot and J. Behr, Org. Biomol. Chem., 2012, 10, 5592 DOI: 10.1039/C2OB25727K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements